questionText: To ask the Secretary of State for Health and Social Care, what recent discussions he has had with the National Institute for Health and Care Excellence on approval of Skyclarys; and if he will consider the urgent provision of Skyclarys for patients on an interim basis.
answerText: The National Institute for Health and Care Excellence (NICE) initiated the appraisal of Skyclarys (omaveloxolone) for the treatment of Friedrich’s Ataxia for people aged 16 years old and over in anticipation of a licence bring granted by the Medicines and...
heading: Omaveloxolone